Hong Kong's principal teaching hospital, where living-donor liver transplantation for liver cancer and nasopharyngeal cancer research were advanced.
Queen Mary Hospital, opened in 1937, is the teaching hospital of the University of Hong Kong's Li Ka Shing Faculty of Medicine and hosts the HKU Clinical Trials Centre and the Hong Kong Cancer Registry's largest referral base. HKU surgeons under Sheung-Tat Fan and Chung-Mau Lo pioneered adult right-lobe living-donor liver transplantation and set standards for hepatocellular carcinoma resection, while HKU's Centre for Nasopharyngeal Carcinoma Research and its clinical oncologists have shaped EBV-DNA based staging and induction chemotherapy in NPC. The hospital also runs the territory's bone marrow transplant service and phase 1 unit, and HKU pathology contributed to early CAR-T and hepatitis-B related HCC studies. HKU is a partner of the Hong Kong Genome Project.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Queen Mary Hospital, including child institutions. 170 works · 1,780 citations · 74% open access · 14% clinical trials · 3% reviews.
Shares Robotic & minimally invasive surgery, Hepatocellular carcinoma, Acute myeloid leukaemia, Head and neck squamous cell carcinoma.
Shares Plasma EBV DNA, Liquid biopsy (ctDNA), Hepatocellular carcinoma, Head and neck squamous cell carcinoma.
Shares Robotic & minimally invasive surgery, Hepatocellular carcinoma, Non-small-cell lung cancer.
Shares Robotic & minimally invasive surgery, Hepatocellular carcinoma, Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
Shares Robotic & minimally invasive surgery, Hepatocellular carcinoma, Acute myeloid leukaemia.
Shares Robotic & minimally invasive surgery, Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
Shares Robotic & minimally invasive surgery, Hepatocellular carcinoma.
Shares Robotic & minimally invasive surgery, Hepatocellular carcinoma.